BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 22447954)

  • 1. Activation of the TLR4 signaling pathway and abnormal cholesterol efflux lead to emphysema in ApoE-deficient mice.
    Goldklang M; Golovatch P; Zelonina T; Trischler J; Rabinowitz D; Lemaître V; D'Armiento J
    Am J Physiol Lung Cell Mol Physiol; 2012 Jun; 302(11):L1200-8. PubMed ID: 22447954
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Apolipoprotein E deficiency and high-fat diet cooperate to trigger lipidosis and inflammation in the lung via the toll-like receptor 4 pathway.
    Ouyang Q; Huang Z; Lin H; Ni J; Lu H; Chen X; Wang Z; Lin L
    Mol Med Rep; 2015 Aug; 12(2):2589-97. PubMed ID: 25975841
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fibronectin Splicing Variants Containing Extra Domain A Promote Atherosclerosis in Mice Through Toll-Like Receptor 4.
    Doddapattar P; Gandhi C; Prakash P; Dhanesha N; Grumbach IM; Dailey ME; Lentz SR; Chauhan AK
    Arterioscler Thromb Vasc Biol; 2015 Nov; 35(11):2391-400. PubMed ID: 26427793
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adipocyte enhancer-binding protein 1 (AEBP1) (a novel macrophage proinflammatory mediator) overexpression promotes and ablation attenuates atherosclerosis in ApoE (-/-) and LDLR (-/-) mice.
    Bogachev O; Majdalawieh A; Pan X; Zhang L; Ro HS
    Mol Med; 2011; 17(9-10):1056-64. PubMed ID: 21687917
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of coexpression of the LDL receptor and apoE on cholesterol metabolism and atherosclerosis in LDL receptor-deficient mice.
    Kawashiri M; Zhang Y; Usher D; Reilly M; Puré E; Rader DJ
    J Lipid Res; 2001 Jun; 42(6):943-50. PubMed ID: 11369802
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Atherogenic and pulmonary responses of ApoE- and LDL receptor-deficient mice to sidestream cigarette smoke.
    Han SG; Howatt DA; Daugherty A; Gairola CG
    Toxicology; 2012 Sep; 299(2-3):133-8. PubMed ID: 22659316
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metabolomic study of the LDL receptor null mouse fed a high-fat diet reveals profound perturbations in choline metabolism that are shared with ApoE null mice.
    Cheng KK; Benson GM; Grimsditch DC; Reid DG; Connor SC; Griffin JL
    Physiol Genomics; 2010 May; 41(3):224-31. PubMed ID: 20197419
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CD11c(+) dendritic cells maintain antigen processing, presentation capabilities, and CD4(+) T-cell priming efficacy under hypercholesterolemic conditions associated with atherosclerosis.
    Packard RR; Maganto-García E; Gotsman I; Tabas I; Libby P; Lichtman AH
    Circ Res; 2008 Oct; 103(9):965-73. PubMed ID: 18832748
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Apolipoprotein E modulates clearance of apoptotic bodies in vitro and in vivo, resulting in a systemic proinflammatory state in apolipoprotein E-deficient mice.
    Grainger DJ; Reckless J; McKilligin E
    J Immunol; 2004 Nov; 173(10):6366-75. PubMed ID: 15528376
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Noninvasive imaging of atherosclerotic lesions in apolipoprotein E-deficient and low-density-lipoprotein receptor-deficient mice with annexin A5.
    Isobe S; Tsimikas S; Zhou J; Fujimoto S; Sarai M; Branks MJ; Fujimoto A; Hofstra L; Reutelingsperger CP; Murohara T; Virmani R; Kolodgie FD; Narula N; Petrov A; Narula J
    J Nucl Med; 2006 Sep; 47(9):1497-505. PubMed ID: 16954559
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetic deletion of low density lipoprotein receptor impairs sterol-induced mouse macrophage ABCA1 expression. A new SREBP1-dependent mechanism.
    Zhou X; He W; Huang Z; Gotto AM; Hajjar DP; Han J
    J Biol Chem; 2008 Jan; 283(4):2129-38. PubMed ID: 18029360
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of macrophage ApoE on atherosclerosis in LDL-receptor deficient mice.
    Tennert C; Teupser D; Mueller MA; Wilfert W; Renner-Müller I; Stein O; Stein Y; Sippel AE; Wolf E; Thiery J
    Biochem Biophys Res Commun; 2007 Sep; 361(3):574-9. PubMed ID: 17669363
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Augmented atherogenesis in LDL receptor deficient mice lacking both macrophage ABCA1 and ApoE.
    Lammers B; Zhao Y; Hoekstra M; Hildebrand RB; Ye D; Meurs I; Van Berkel TJ; Van Eck M
    PLoS One; 2011; 6(10):e26095. PubMed ID: 22022523
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Low carbohydrate, high protein diet promotes atherosclerosis in apolipoprotein E/low-density lipoprotein receptor double knockout mice (apoE/LDLR(-/-)).
    Kostogrys RB; Franczyk-Żarów M; Maślak E; Gajda M; Mateuszuk L; Jackson CL; Chłopicki S
    Atherosclerosis; 2012 Aug; 223(2):327-31. PubMed ID: 22771189
    [TBL] [Abstract][Full Text] [Related]  

  • 15. EP 80317, a ligand of the CD36 scavenger receptor, protects apolipoprotein E-deficient mice from developing atherosclerotic lesions.
    Marleau S; Harb D; Bujold K; Avallone R; Iken K; Wang Y; Demers A; Sirois MG; Febbraio M; Silverstein RL; Tremblay A; Ong H
    FASEB J; 2005 Nov; 19(13):1869-71. PubMed ID: 16123174
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Constitutive androstane receptor activation decreases plasma apolipoprotein B-containing lipoproteins and atherosclerosis in low-density lipoprotein receptor-deficient mice.
    Sberna AL; Assem M; Xiao R; Ayers S; Gautier T; Guiu B; Deckert V; Chevriaux A; Grober J; Le Guern N; Pais de Barros JP; Moore DD; Lagrost L; Masson D
    Arterioscler Thromb Vasc Biol; 2011 Oct; 31(10):2232-9. PubMed ID: 21778422
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thymoquinone reduces cardiac damage caused by hypercholesterolemia in apolipoprotein E-deficient mice.
    Xu J; Zhu L; Liu H; Li M; Liu Y; Yang F; Pei Z
    Lipids Health Dis; 2018 Jul; 17(1):173. PubMed ID: 30049280
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular imaging of matrix metalloproteinase expression in atherosclerotic plaques of mice deficient in apolipoprotein e or low-density-lipoprotein receptor.
    Ohshima S; Petrov A; Fujimoto S; Zhou J; Azure M; Edwards DS; Murohara T; Narula N; Tsimikas S; Narula J
    J Nucl Med; 2009 Apr; 50(4):612-7. PubMed ID: 19289429
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vascular-directed tissue factor pathway inhibitor overexpression regulates plasma cholesterol and reduces atherosclerotic plaque development.
    Pan S; White TA; Witt TA; Chiriac A; Mueske CS; Simari RD
    Circ Res; 2009 Sep; 105(7):713-20, 8 p following 720. PubMed ID: 19713537
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ApoE-dependent modulation of HDL and atherosclerosis by G2A in LDL receptor-deficient mice independent of bone marrow-derived cells.
    Parks BW; Srivastava R; Yu S; Kabarowski JH
    Arterioscler Thromb Vasc Biol; 2009 Apr; 29(4):539-47. PubMed ID: 19164809
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.